Skip to content
- 30.11.2025 15:01 Merck to Acquire Cidara for $9.2 Billion, Expanding Flu Prevention Pipeline
- 30.11.2025 12:01 Eli Lilly and Novo Nordisk Disown Mangoceuticals’ GLP-1RA Partnership Claim
- 30.11.2025 09:01 Mikael Dolsten Withdraws Board Candidacy at Novo Nordisk Amid Leadership Changes
- 30.11.2025 06:01 Otsuka’s HAE med Dawnzera, Lilly’s oral SERD Inluriyo among drugs scoring EU endorsements
- 30.11.2025 03:00 Medicxi Secures €500 Million for New Biotech Fund to Transform Patient Care
- 30.11.2025 00:00 Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy
- 29.11.2025 21:01 CHMP Recommends Ten New Medicines for Approval at November 2025 Meeting
- 29.11.2025 18:01 LB Pharmaceuticals, Celldex Hire Commercial Chiefs as Launch Plans Ramp Up
- 29.11.2025 15:00 Organon and Henlius’ Poherdy, first biosimilar to Roche’s Perjeta, scores FDA nod
- 29.11.2025 12:01 General Proximity and Daiichi Sankyo Link on Oncology
- 29.11.2025 09:00 EMA Recommends Marketing Authorisation for Teizeild to Delay Type 1 Diabetes Onset
- 29.11.2025 06:02 Biopharma Industry Gathers Momentum in Q3
- 29.11.2025 03:05 ByHeart Issues Nationwide Recall Amid Infant Botulism Outbreak Linked to Its Formula
- 28.11.2025 21:00 The Era of Safe Bets in Psychiatric Medicine is Over
- 28.11.2025 18:00 Eisai and Biogen Secure MHRA Approval for Leqembi in Early Alzheimer’s Treatment
- 28.11.2025 14:59 Lundbeck Disrupts Alkermes’ Planned $2.1B Purchase of Avadel with Higher Bid
- 28.11.2025 09:00 Medicxi closes fifth fund to back ‘asset-centric’ startups
- 28.11.2025 06:04 Pfizer Launches PD-1xVEGF Trials Amidst Akeso’s Survival Milestone and Lilly’s Expansion
- 28.11.2025 03:02 Survey reveals ‘cardiology deserts’ at heart of Amgen-backed campaign
- 28.11.2025 00:00 Genetic Agency on Display at GATC 2025
- 27.11.2025 21:02 FDA Approves Kura and Kyowa Kirin’s Drug for Acute Myeloid Leukemia
- 27.11.2025 18:00 Office of Infectious Diseases Research Activities Unveils New Initiatives
- 27.11.2025 15:00 Accelerating Clinical Decisions Through Faster Access to Imaging Data
- 27.11.2025 09:00 Merck Achieves Breakthrough in Heart Disease Treatment with New PCSK9 Drug
- 27.11.2025 00:00 Estonia’s Digital Health DNA: Trust, Data, and Biotech in Focus
- 26.11.2025 21:00 Pfizer Completes Up to $10 Billion Acquisition of Obesity Biotech Metsera
- 26.11.2025 15:01 Day One snaps up ADC maker Mersana in backloaded buyout deal
- 26.11.2025 09:00 Bavarian Nordic Board Chair Exits Following Failed Private Equity Takeover
- 26.11.2025 06:00 Kura Oncology Secures FDA Approval for First Leukemia Drug, Komzifti
- 26.11.2025 03:00 Korro to cut staff, shift strategy as RNA editing drug misses mark in early testing
- 26.11.2025 00:01 AbbVie and Calico Conclude 11-Year Research Partnership in Aging
- 25.11.2025 21:00 Multiomics Uncovers Immune Mechanisms in Pig Kidney Rejection
- 25.11.2025 18:01 MacroGenics Halts Development of PD-1xCTLA-4 Bispecific in Prostate Cancer
- 25.11.2025 12:00 Abeona’s skin disease cell therapy launch stymied by false-positive sterility test
- 25.11.2025 09:01 Lilly and Novo Deny Partnership Claims with Mangoceuticals for Obesity Meds
- 25.11.2025 06:00 GOP ACA Proposal Faces Tepid Reception from Think Tanks
- 25.11.2025 03:01 FDA Unveils Blueprint for Personalized Gene-Editing Therapies
- 25.11.2025 00:00 Biological Data Centers: The Future of Drug Discovery and Human Evidence
- 24.11.2025 21:00 BioNTech Unveils Insights on PD-(L)1xVEGF Bispecifics at R&D Day
- 24.11.2025 18:01 Pfizer Signals Brewing Digital Health Work with New Leadership Role
- 24.11.2025 15:00 Dexcom Launches Awareness Campaign Featuring 16 Advocates for World Diabetes Day
- 24.11.2025 12:00 Merck KGaA Still in Tariff Talks with the White House, Weeks After Deal Announcement
- 24.11.2025 09:00 Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
- 24.11.2025 06:00 U.S. Patent Office Policies Face Criticism from Drug Companies Amid New Malaria Drug Development
- 24.11.2025 00:04 AEON Biopharma Reports Positive & Robust Biosimilarity Results: Identical Amino Acid Sequence & Highly Similar Functional Analysis Data
- 23.11.2025 21:01 Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
- 23.11.2025 18:00 Common Epstein–Barr Virus Reprograms B Cells to Drive Lupus
- 23.11.2025 15:00 Adagene Licenses SAFEbody Technology to Third Arc Bio for Two CD3 T Cell Engagers
- 23.11.2025 12:00 Wild Poliovirus Detected in Germany
- 23.11.2025 09:00 Gate Bioscience captures another $65M with new take on protein degradation
- 23.11.2025 06:00 Pfizer finalizes Metsera buy after contentious bidding war with Novo Nordisk
- 23.11.2025 03:00 FDA Unveils New Pathway to Usher Bespoke Therapies to Market
- 22.11.2025 21:00 Bausch + Lomb CEO Brent Saunders Discusses Company Turnaround and Future Directions
- 22.11.2025 18:00 Uniqure CEO Highlights FDA Concerns During Investor Dinner
- 22.11.2025 15:00 Agios Pharmaceuticals Faces Critical FDA Decision on Pyrukynd Approval for Thalassemia
- 22.11.2025 06:00 Eisai Reports 48-Month Efficacy Data on Lecanemab at Neurology Congress
- 22.11.2025 03:00 EuropaBio Calls for Bold Approach to Investment Amid EU Biotech Act
- 22.11.2025 00:00 CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value
- 21.11.2025 21:00 Chiesi and Aliada Sign Exclusive License Agreement for Enzyme Replacement Therapies
- 21.11.2025 18:00 New U.S. Patent Office Policies May Hinder Access to Lower-Cost Medicines
- 21.11.2025 12:00 Digital Divide in SNAP Benefits Leaves Seniors Behind
- 21.11.2025 09:01 Trump’s GLP-1 Deal Promises Broader Access to Weight Loss Drugs
- 21.11.2025 06:01 Boryung Breaks Ground on Penicillin Plant Expansion in South Korea
- 21.11.2025 03:00 Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings
- 21.11.2025 00:00 BostonGene and Kyoto University Collaborate on Oesophageal Cancer Drug Development
- 20.11.2025 18:03 Novartis to Seek Approval for Novel Antimalarial Drug Following Successful Study
- 20.11.2025 15:00 FDA unveils new regulatory roadmap for bespoke drug therapies
- 20.11.2025 12:04 Novartis’ Phase 3 Trial Confirms Efficacy of New Antimalarial GanLum Against Resistance
- 20.11.2025 09:00 FDA Announces New Regulatory Pathway for Personalized Rare Disease Therapies
- 20.11.2025 06:00 FDA Officials Unveil Roadmap for Personalized Gene-Editing Treatments
- 20.11.2025 00:01 Targeting Ceramides Prevents Acute Kidney Injury in Mice
- 19.11.2025 21:00 Lilly Drops CVS as Drug Benefits Manager — Report
- 19.11.2025 12:00 WuXi AppTec Establishes European Headquarters in Munich
- 19.11.2025 09:00 Sandoz CEO forecasts a Q1 or Q2 market entry for semaglutide biosimilars in Canada
- 19.11.2025 06:01 New Genes Found to Regulate Glycosylation of Immunoglobulin
- 19.11.2025 03:02 Africa’s Vaccine Manufacturing Ecosystem Requires Collaborative CDMO and Supplier Engagement
- 19.11.2025 00:01 Machine-Learning-Assisted mAb Yield Improvement
- 18.11.2025 21:00 New Insights into Protein Production Challenges in CHO Cells
- 18.11.2025 15:00 Novel Nasal Spray Vaccine for Pertussis Shows Promise
- 18.11.2025 12:00 AI Water Usage: Discrepancies in Environmental Impact Reporting
- 18.11.2025 09:01 Richard Pazdur, longtime FDA oncology leader, to head agency’s main drug office
- 18.11.2025 06:02 Alkermes Reports Mixed Phase 2 Narcolepsy Data, Stock Declines
- 17.11.2025 21:00 Recall roundup: Fresenius, Sun and Teva among drugmakers pulling products in recent weeks
- 17.11.2025 15:02 Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data
- 17.11.2025 12:00 Eli Lilly Approaches $1 Trillion Valuation Amid Robust Pipeline and Market Position
- 17.11.2025 09:01 The Competitive Landscape for PD-(L)1xVEGF Bispecifics is Evolving
- 17.11.2025 06:00 Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension to the FDA
- 17.11.2025 03:01 Novartis Opens New Radioligand Therapy Manufacturing Facility as Part of $23B US Expansion Plan
- 17.11.2025 00:01 Modulight secures $12m to shine precise light on neurological diseases
- 16.11.2025 21:00 FDA Appoints Richard Pazdur as Top Drug Regulator Amid Cancer Drug Gold Rush
- 16.11.2025 18:01 A MAHA Summit, minus the radical transparency
- 16.11.2025 09:00 Lundbeck, Otsuka back survey uncovering ‘blind spot’ around Alzheimer’s agitation
- 16.11.2025 06:02 Ovid Therapeutics CEO Jeremy Levin to Step Down, Succeeded by COO Meg Alexander
- 16.11.2025 00:00 J&J, Legend Withdraw ASH Abstract Assessing Carvykti Against Gilead, Arcellx’s Rival CAR-T
- 15.11.2025 21:01 Bayer CEO Remains Optimistic Amid Stagnant Pharma Sales and Launch of Lynkuet
- 15.11.2025 18:01 Dyno Therapeutics and Trisk Bio Partner for Strategic Manufacture
- 15.11.2025 15:01 Evotec earns milestone payment as FDA clears IND for CELMoD candidate
- 15.11.2025 12:02 Global Vaccination Efforts Face Legal Challenges Amid Rising Hesitancy
- 15.11.2025 03:01 March Bio’s MB-105 Gains FDA RMAT for CD5+ T-Cell Lymphoma
- 15.11.2025 00:02 Richard Pazdur’s Appointment as Head of FDA Drug Division Signals Positive Change for Pharma and Patients
- 14.11.2025 21:00 Covid-era rules for addiction medication, Ritalin are extended again
- 14.11.2025 18:00 FDA Appoints Richard Pazdur as New CDER Director Following Tidmarsh’s Resignation
- 14.11.2025 15:00 Richard Pazdur Appointed Director of FDA’s Drug Center Amid Controversy
- 14.11.2025 12:02 AHA 2025: Gene therapy shows potential in chronic heart failure
- 14.11.2025 06:00 Top biopharma execs set to appear at MAHA Summit
- 14.11.2025 02:59 Health Secretary Robert F. Kennedy Jr. to Address Exclusive MAHA Summit with Biotech Leaders
- 14.11.2025 00:00 Physician Attends Anti-Vaccine Conference, Highlights Growing Concerns Among Healthcare Professionals
- 13.11.2025 21:00 FDA Calls for Black Box Warning to Be Removed from HRT Products
- 13.11.2025 18:01 Zag Bio Launches with $80M to Enhance Treg Function in Type 1 Diabetes
- 13.11.2025 12:00 Novartis Considers Expanding Direct-to-Patient Drug Sales Amid Pricing Concerns
- 13.11.2025 09:00 Baxter Healthcare Issues Class 2 Recall for Compound Sodium Lactate Solution Due to Packaging Error
- 13.11.2025 06:02 Domain Therapeutics begins patient dosing in phase 1/2 trial of DT-7012
- 12.11.2025 21:02 CSL Delays Flu Vaccine Unit Spinoff as US Immunization Rates Plummet
- 12.11.2025 18:00 Miriam Merad’s 20-Year Quest to Understand Macrophages is Redefining Cancer Immunotherapy
- 12.11.2025 15:00 Global Health Initiatives Essential for Global Security, Experts Assert
- 12.11.2025 09:00 Hemab secures $157 million in Series C funding to advance bleeding disorder therapies
- 12.11.2025 06:00 MSD Receives FDA Approval for Winrevair’s Updated Indication
- 12.11.2025 03:00 New Antibiotic Precursor from Streptomyces coelicolor Shows Promise Against Resistant Bacteria
- 12.11.2025 00:00 Bioengineering Advances Inspired by Coral’s Natural “Jamming System”
- 11.11.2025 21:00 MARTi Software Transforms Nanopore Metagenomics with Real-Time Analysis
- 11.11.2025 18:01 BioMarin to Divest Hemophilia Gene Therapy Roctavian Amid Sluggish Sales
- 11.11.2025 12:00 Organon CEO Exits After Internal Probe Over ‘Channel Stuffing’ to Boost Sales
- 11.11.2025 09:02 Optimers Revolutionize Target Discovery and Therapeutic Development
- 11.11.2025 06:01 Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development Scheduled for May 29, 2024
- 11.11.2025 03:03 Eli Lilly Collaborates with Shaquille O’Neal to Elevate Sleep Apnea Awareness Campaign
- 11.11.2025 00:00 Millions to Lose SNAP Benefits Amid Government Shutdown, Health Experts Warn of Dire Consequences
- 10.11.2025 21:02 Pancreatic Cancer Surgeon Dr. Michael Zinner Confronts His Own Diagnosis
- 10.11.2025 18:02 Intellia Halts Two CRISPR Trials Following Liver Toxicity Incident
- 10.11.2025 15:01 Medicare Threatens Funding Cut for HCA’s Mission Hospital Due to Safety Issues
- 10.11.2025 09:02 Guardant and Zephyr AI pair up to advance cancer biomarker development
- 10.11.2025 06:00 Organon CEO stands down amid contraceptive sales malpractice probe
- 10.11.2025 03:00 Improving vaccine outreach and education with real-world data
- 10.11.2025 00:00 Intellia pauses two CRISPR drug studies after safety scare
- 09.11.2025 15:00 Novartis to Acquire Avidity for $12B, Bolstering Neuroscience Pipeline
- 09.11.2025 12:00 Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets Due to Mislabeling
- 09.11.2025 09:01 CDMO Catalent Refines Brand to Highlight ‘Missions That Matter’ as Novo Buyout Anniversary Approaches
- 09.11.2025 06:00 GSK targets Syndivia’s prostate cancer ADC in £268m buy
- 09.11.2025 03:00 Zenas’ multiple sclerosis drug slows new brain lesions in mid-stage trial
- 09.11.2025 00:00 Bayer Receives FDA Approval for Non-Hormonal Menopause Therapy
- 08.11.2025 18:01 Novartis CEO says $12B Avidity deal could have been ‘twice as big’
- 08.11.2025 15:02 Zenas BioPharma Reports Significant Phase 2 MoonStone Trial Outcomes for Obexelimab in Relapsing Multiple Sclerosis
- 08.11.2025 12:02 IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
- 08.11.2025 06:03 Insights from Endpoints AI Day: Industry Leaders Discuss Progress and Challenges
- 08.11.2025 03:00 Curia Invests $4 Million to Enhance Sterile API Manufacturing
- 08.11.2025 00:00 ALS Linked to Proteostatic Burden in Vulnerable Motor Neurons
- 07.11.2025 20:59 WuXi AppTec to Divest Clinical Services to Focus on Manufacturing Business
- 07.11.2025 18:00 Causeway Therapeutics Seeks Funding Boost Following Promising Tendinopathy Study Results
- 07.11.2025 12:00 BridgeBio to seek approval of limb-girdle drug following new study data
- 07.11.2025 09:00 Eli Lilly Acquires Adverum to Target Wet AMD Market
- 07.11.2025 06:03 Innovent and Lilly’s Mazdutide Outperforms Novo’s Semaglutide in Head-to-Head Diabetes Study
- 07.11.2025 00:00 CHM Endorses Changes to Isotretinoin Prescribing Guidance
- 06.11.2025 21:02 Commission on Human Medicines Releases Key Recommendations for Isotretinoin Safety
- 06.11.2025 18:00 Merck nabs updated FDA label for soon-to-be-blockbuster Winrevair
- 06.11.2025 15:01 UK Watchdog Finds AstraZeneca and Organon in Breach of Pharma Code
- 06.11.2025 12:01 Excellergy eyes IgE therapy space as Xolair nears patent expiry
- 06.11.2025 09:05 BoltzGen Democratizes AI Therapeutic Design, Expands Druggable Universe
- 06.11.2025 03:01 Hemab Secures $157M to Advance Innovative Treatments for Coagulation Disorders
- 06.11.2025 00:03 Chugai Acquires Renalys, Enhancing Its Kidney Disease Portfolio
- 05.11.2025 21:00 Hemab collects another $157M to go after ‘underserved’ blood diseases
- 05.11.2025 18:01 Organon CEO exits, company goes on hunt for successor as internal probe turns up ‘improper’ Nexplanon sales tactics
- 05.11.2025 15:01 Community pharmacies and BioPharma: Advancing whole-patient care together
- 05.11.2025 06:02 Top 3 Biotech ETFs Experience Significant Gains Amid Market Recovery
- 05.11.2025 03:02 Novartis to acquire Avidity Biosciences for $12 billion
- 05.11.2025 00:03 Novartis to Acquire Avidity Biosciences for $12 Billion, Expanding RNA Therapeutics Portfolio
- 04.11.2025 21:04 Novartis to acquire Avidity in $12B bet on RNA drugs for neuromuscular disease
- 04.11.2025 15:00 Icon warns of macro environment headwinds as Medpace maintains revenue momentum
- 04.11.2025 09:00 New Insurance Company Downcoding Sparks Controversy Among Pharma Professionals
- 04.11.2025 06:00 The Compensation Debate for Medical Research Volunteers: A Critical Examination
- 04.11.2025 03:00 Tackling Antimicrobial Resistance and Glioblastoma with Biology-First AI Models
- 04.11.2025 00:01 FDA Approves Bayer’s Hot Flash Treatment
- 03.11.2025 21:01 Biogen Licenses Potential Immune Drug Targeting C5aR1 from Vanqua Bio
- 03.11.2025 18:00 FDA Discovers Unauthorized Indian API Warehouse Infested with Lizards and Cats
- 03.11.2025 15:00 Halda reveals first clinical data of RIPTAC drug in prostate cancer
- 03.11.2025 12:00 Engineered Sweet-Smelling Fungus Lures Mosquitoes to Their Death
- 03.11.2025 09:00 Artificial Intelligence in the Emerald City and Targeting Colon Cancer Stem Cells
- 03.11.2025 06:01 Eli Lilly Considers Philadelphia for Next Gateway Labs Site
- 03.11.2025 00:00 Lilly Acquires Adverum Amid Gene Therapy Market Challenges
- 02.11.2025 21:00 Sharp Services Invests $100 Million in US & European Facilities to Increase Capacity & Service Offerings
- 02.11.2025 18:00 UK Regulators Seize Illegal Weight Loss Drugs Amid Global Pricing Shake-Up
- 02.11.2025 15:01 Serán BioScience Expands Commercial Manufacturing With New Campus in Bend, Oregon
- 02.11.2025 12:00 Orion Secures Exclusive License for Abzena’s Monoclonal Antibody Targeting High Unmet Cancer Need
- 02.11.2025 09:04 Sanofi Reports 8% Decline in Vaccine Sales Due to Sluggish Flu Shot Uptake
- 02.11.2025 00:04 With FDA Nod, Bayer’s Lynkuet Enters US Market for Nonhormonal Menopause Symptom Meds
- 01.11.2025 21:01 Aenova Expands Sterile Fill & Finish Manufacturing Capacity at its Latina Site
- 01.11.2025 18:00 Kindeva Promotes David Stevens to President, Strengthening Leadership in CDMO Sector
- 01.11.2025 09:00 Lilly and Incyte to Seek Approval of Alopecia JAK Inhibitor in Children
- 01.11.2025 06:02 Eli Lilly to Seek Olumiant Approval in Adolescents with Alopecia
- 01.11.2025 00:00 Merus Expands Colorectal Cancer Focus with Promising Petosemtamab Data
- 31.10.2025 18:05 FDA Launches Priority Review Voucher Program Under Commissioner Marty Makary
- 31.10.2025 15:00 Real-Time Epigenetic Sensor Tracks Post-Translational Modification Dynamics
- 31.10.2025 12:00 Ro Aims to Quantify ‘Food Noise’ in Obesity Management
- 31.10.2025 09:00 Biopharma Executives Experience Wonder and Worry at STAT Summit
- 31.10.2025 00:01 Chugai Acquires Partial Rights to IgA Nephropathy Drug Amid Rising Concerns Over Drug Pricing
- 30.10.2025 21:03 ICMRA Summit 2025: EMA concludes its two mandates as chair
- 30.10.2025 15:00 Novo Nordisk Appoints New Corporate Affairs Executive Amid Board Turmoil
- 30.10.2025 08:59 Sanofi’s Dupixent Sales Surpass 4 Billion Euros, Offsetting Vaccine Revenue Decline
- 30.10.2025 06:03 MHRA Smashes Major Illicit Weight Loss Medicine Production Facility in Record Seizure
- 30.10.2025 00:05 Galderma outlays $650m for US manufacturing as Nemluvio sales soar
- 29.10.2025 21:02 EUROAPI Launches Med4Cure Project to Enhance Pharma Sovereignty
- 29.10.2025 18:00 CF buyers club aims to grow access to Vertex’s Trikaftra through trade-policy workaround
- 29.10.2025 15:00 Roche’s Chugai Strikes $200M M&A Deal to Take Over IgAN Asset in Several Asian Countries
- 29.10.2025 12:00 Algorithms Used to Determine Medicaid Eligibility for Home Care Vary Widely Among States
- 29.10.2025 09:02 TrumpRx and Most Favored Nation Policy Will Not Lower Drug Prices for Patients
- 29.10.2025 06:00 Ro Launches New Scale to Measure ‘Food Noise’ in Obesity Care
- 29.10.2025 03:00 Trump’s $150-per-month GLP-1 plan raises skepticism among pharma professionals
- 29.10.2025 00:00 GSK’s Blenrep Gains FDA Approval for Myeloma Treatment
- 28.10.2025 21:02 New Insights into Obesity and Fat Metabolism: The Role of Nuclear HSL
- 28.10.2025 18:04 Advocacy Groups Launch Buyer’s Club for Affordable Generic Cystic Fibrosis Treatment
- 28.10.2025 15:01 Hitchhiking DNA in C. elegans Solves Telomerase Puzzle, with Regenerative Promise
- 28.10.2025 12:04 FDA Warns Against vROX Due to Hidden Drug Ingredient
- 28.10.2025 09:00 FDA clears return of GSK’s once-withdrawn multiple myeloma drug
- 28.10.2025 06:05 FDA Warns Against SPARTAN Due to Hidden Drug Ingredient
- 28.10.2025 00:00 Real-Time Embryo Imaging Raises Questions About IVF Screening Accuracy
- 27.10.2025 20:59 FDA Delivers Split Decision on GSK’s Blood Cancer Drug Blenrep, Approving Its Use in Some Cases
- 27.10.2025 15:00 Inhibrx to Submit Bone Cancer Drug to FDA Next Year Following Promising Data
- 27.10.2025 12:01 10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents
- 27.10.2025 09:01 FDA Approves First Generic Drugs, Enhancing Market Competition
- 27.10.2025 06:01 Startups Accelerate FDA Engagement and Biotech Growth in North Carolina
- 27.10.2025 03:01 GSK’s once-withdrawn Blenrep gets second wind in US with FDA nod to treat certain myeloma patients
- 27.10.2025 00:04 Trump Administration’s IVF Initiative Sparks Transformation in Fertility Sector
- 26.10.2025 18:03 Health Tech Investors Are Getting Picky
- 26.10.2025 12:02 Merck KGaA to End API Work at Irish Plant After Strategic Portfolio Review
- 26.10.2025 09:01 FDA Releases Guidance to Elevate Patient Perspectives in Drug Development
- 26.10.2025 03:00 Lonza anticipates increased CDMO contracts amid Galderma’s $650M US investment
- 26.10.2025 00:01 Roche Engages in Ongoing Discussions with US Government Regarding Drug Pricing, CEO Reports
- 25.10.2025 21:00 Ventyx shares soar after study suggests cardiovascular benefits for experimental drug
- 25.10.2025 12:00 Tango Therapeutics Advances Pancreatic Cancer Drug into Phase 3 with $225 Million Raise
- 25.10.2025 09:00 Biotech recovery in Q3 2025 as venture funding grows 70.9% from Q2 2025
- 25.10.2025 06:01 Lonza’s Recently Purchased Calif. Biologics Site Plays Key Role in Sales Rebound
- 25.10.2025 03:01 DeSantis Downplays Importance of Health Insurance Amid Ongoing Government Shutdown
- 24.10.2025 21:00 Ventyx’s Stock Soars on Cardiovascular Data for NLRP3 Drug
- 24.10.2025 12:00 Joe Kennedy III Critiques Uncle RFK Jr.’s Leadership Over Health System Concerns
- 24.10.2025 09:00 Academic Medicine Faces Radical Democratization Amid Funding Cuts and AI Influence
- 24.10.2025 06:00 Researcher Uncovers Cellular Connections in Zika Virus Pathway to Placenta
- 24.10.2025 03:00 FDA Names 9 First Recipients of 1- to 2-Month Priority Review Vouchers
- 24.10.2025 00:00 Gut Microbiome Reduces Brain’s Interest in Alcohol
- 23.10.2025 21:00 Cryo-ET Reveals “Kiss-Shrink-Run” Neurotransmission Mechanism
- 23.10.2025 18:01 FDA Announces First Nine Recipients of Priority Drug Review Vouchers
- 23.10.2025 12:03 Cell Signaling-Inspired DNA Sensor Enables Molecular Detection from Single Blood Drop
- 23.10.2025 09:00 FDA Awards First-Ever National Priority Vouchers to Nine Sponsors
- 23.10.2025 06:01 Trump Administration Partners with EMD Serono to Enhance Fertility Treatment Accessibility
- 23.10.2025 03:00 I-Mab Remakes Itself, with Plans for Hong Kong Listing, Retinal R&D, and a New Name
- 23.10.2025 00:02 FDA Issues Guidance on Decentralized Elements in Clinical Trials
- 22.10.2025 21:01 Former NIH Leaders Warn of Ongoing Turmoil at the Agency
- 22.10.2025 18:00 Drug Supply Chain Security Act (DSCSA) Advances Traceability in U.S. Drug Distribution
- 22.10.2025 09:00 Pfizer CEO Urges US to Compete with China’s Biopharma Ecosystem
- 22.10.2025 06:00 HLTH Conference Sparks Surge of Industry Announcements
- 22.10.2025 03:00 Illumina Unveils Constellation Technology and 5-Base Solution at ASHG
- 22.10.2025 00:00 ASHG 2025: Functional Impact of Non-Coding RNA Uncovered in Human Disease
- 21.10.2025 12:03 AMA President Defends Restraint in Advocacy Amid Trump Administration Criticism
- 21.10.2025 09:00 Biotech Leaders Warn FDA Uncertainty Threatens Drug Development
- 21.10.2025 03:01 Novartis confirms drug’s benefits in rare kidney disease as competitors loom
- 20.10.2025 21:00 SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows
- 20.10.2025 18:00 Medicines: Apply for a Variation to Your Marketing Authorisation
- 20.10.2025 12:01 AstraZeneca Doubles Lokelma Output with $445M Texas Plant Expansion
- 20.10.2025 09:00 Plasmidsaurus Launches Ultrafast RNA-Seq Service
- 20.10.2025 06:01 J&J claims success in study testing earlier Tecvayli use in multiple myeloma
- 20.10.2025 03:02 Novo Nordisk Acquires Omeros’ Rare Disease Asset for Up to $2.1 Billion
- 20.10.2025 00:00 Praxis Precision Medicines Achieves Significant Success in Phase 3 Essential Tremor Trials, Stock Surges
- 19.10.2025 18:00 Are PD-1xVEGF Bispecifics Being Tested in the Wrong Kinds of Cancer?
- 19.10.2025 15:02 Dianthus Therapeutics Licenses Autoimmune Asset from Chinese Biotech for $30 Million
- 19.10.2025 12:01 Whoop Expands from Wellness to Healthcare, Valued at $3.6 Billion
- 19.10.2025 09:02 Novo Strikes $2.1 Billion Deal with Omeros for Rare Disease Drug
- 19.10.2025 06:01 AstraZeneca opens $445M expansion of Lokelma factory; Avidity Bio delays BLA for Duchenne drug
- 19.10.2025 03:04 GSK’s Minimal Role in Leucovorin Update Amid FDA Request
- 19.10.2025 00:01 Enterome Receives FDA Fast Track Designation in Follicular Lymphoma for Lead OncoMimics Immunotherapy
- 18.10.2025 21:02 Dianthus and Boehringer Ingelheim Lead High-Dollar Licensing Deals in Asia
- 18.10.2025 18:58 Pfizer Acquires Metsera for Nearly $5 Billion, Insights from Clive Meanwell
- 13.10.2025 18:00 Novel Antibody Technologies Expand Potential Cancer Applications
- 13.10.2025 15:02 Boehringer Ingelheim Breathes New Life into Lung Fibrosis Field with FDA Approval for Jascayd
- 13.10.2025 12:00 Orally Disintegrating Tablets: A Growing Market with Unique Formulation Challenges
- 13.10.2025 09:00 Généthon Aims to Reduce CGT Costs Through Innovative Biomanufacturing
- 13.10.2025 06:00 Quotient Sciences’ Platform Accelerates Development of Poorly Soluble Drugs
- 13.10.2025 03:00 Lipid Formulation Development: Softgels as the Preferred Technology
- 13.10.2025 00:03 Mitigating Disruptions in API Supply: Building Resilient and Redundant Sourcing Strategies
- 12.10.2025 21:05 Pharmaceutical Industry Embraces AI for Digital Transformation
- 12.10.2025 18:00 Staying Ahead of Green Propellant Regulations in pMDIs
- 12.10.2025 15:02 CPHI Frankfurt 2025: A Convergence of Pharma Professionals
- 12.10.2025 12:05 CDC Amends Covid-19, Chickenpox Immunisation Schedule Amid Vaccine Controversy
- 12.10.2025 09:01 MapLight Uses Workaround to Tee Up IPO During Government Shutdown
- 12.10.2025 06:01 Container Selection is Crucial for Addressing Sterile Fill & Finish Challenges in Biologics
- 12.10.2025 03:00 After high-profile FDA exit, Peter Marks lands at Eli Lilly
- 11.10.2025 21:03 Lilly’s Omvoh Benefit Continues for Four Years in UC
- 11.10.2025 18:01 Lipid Excipients Propel Oral Drug Delivery Innovation Amid Formulation Challenges
- 11.10.2025 15:03 Regulatory, policy disruptions are causing consternation among biopharma leaders: report
- 11.10.2025 03:00 MSL’s Kaylee Harrington Highlights Impactful Work on Rural Health Campaigns
- 11.10.2025 00:01 Lexeo Eyes Faster Path to Approval for Friedreich’s Ataxia Gene Therapy
- 10.10.2025 21:02 Mark Alles’ biotech secures $96M for ADC trials from UCLA lab
- 10.10.2025 15:00 Novartis survey reveals critical insights into women’s breast health conversations
- 10.10.2025 14:01 US Regulatory Shift Fuels Domestic Scaling of CGT Manufacturing
- 10.10.2025 12:59 Special report 2025: Meet 20 women reshaping the future of biopharma
- 10.10.2025 12:02 Adicet Reveals Phase 1 Data for Lupus Therapy; Arcus’ ‘Best-in-Class’ Kidney Cancer Drug
- 10.10.2025 10:03 Women CEOs in Biopharma: Gender Diversity, Pay Analysis
- 10.10.2025 09:02 Orca Submits T Cell Therapy for FDA Approval
- 10.10.2025 05:02 Lexeo Reports FDA Open to Accelerated Approval Pathway for Rare Disease Gene Therapy
- 10.10.2025 04:05 Amgen Slashes Cholesterol Drug Prices Amid U.S. Drug Cost Debate
- 10.10.2025 03:00 RheumaGen and SiVEC Biotechnologies Forge CGT Partnership to Tackle Autoimmune Diseases
- 10.10.2025 02:04 Eli Lilly earmarks $1B to boost India manufacturing footprint
- 10.10.2025 01:00 Texas Sees Surge in Measles Cases Linked to Low Vaccination Rates in Schools
- 10.10.2025 00:00 AbbVie Enlists Tyler James Williams to Enhance IBD Treatment Dialogue
- 09.10.2025 23:05 Biomea Fusion Reports Promising Early Phase 2 Data on Diabetes Treatment from Repurposed Menin Inhibitor
- 09.10.2025 22:00 AeroRx Closes $21M Series A to Capitalize on COPD Momentum
- 09.10.2025 21:00 NanoPhoria Raises $98M to Advance Heart Failure Treatment
- 09.10.2025 19:00 OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M
- 09.10.2025 18:00 FDA Lifts Clinical Hold on Neurizon’s ALS Drug
- 09.10.2025 16:00 Venture Financing for mRNA-Based Vaccines Declines 82% in 2025 YTD
- 09.10.2025 15:00 NIH Disbands NExTRAC Advisory Committee Amid Concerns Over Scientific Engagement
- 09.10.2025 14:01 Surge in Demand for Natural Alternatives Following Tylenol Controversy
- 09.10.2025 11:59 Vitamin B12 Deficiency: A Critical Nutritional Insight for Medical Professionals
- 09.10.2025 11:01 Chiesi Group partners Arbor on gene editing programmes
- 09.10.2025 09:02 Nanoparticle Therapy Promotes Aβ Clearance and Cognitive Recovery in Alzheimer’s Mouse Model
- 09.10.2025 08:00 Leukemia Immune Evasion Revealed, Antibody Restores T Cell Attack
- 09.10.2025 07:00 Mojo Max Fusion XXX may be harmful due to hidden drug ingredients
- 09.10.2025 06:00 Gilead inks trio of Biktarvy patent settlements, waylaying US copycats until 2036
- 09.10.2025 05:00 UK Clinical Trial Approval Times Cut in Half with AI and Regulatory Reforms
- 09.10.2025 04:00 Osteo Sin Max may be harmful due to hidden drug ingredients
- 09.10.2025 02:01 Insilico’s AI Workflow Has Two Jobs: Discover Compounds, Thwart Competitors
- 09.10.2025 01:04 Asimov Launches Stable AAV Producer Cell Lines for Viral Vector Manufacturing
- 08.10.2025 22:00 Acting CDC Director Calls for MMR Vaccine to be Broken Up into Three Shots
- 08.10.2025 21:00 FDA to Redesign ‘CERSI’ University Collaborations with Funding Changes
- 08.10.2025 20:02 TV Drug Ad Spending Increased in September Despite Federal Crackdown
- 08.10.2025 19:00 CDC Adopts New Covid-19 and Chickenpox Vaccine Recommendations
- 08.10.2025 18:00 CDC Updates COVID and Chickenpox Vaccine Guidance Following ACIP Recommendations
- 08.10.2025 17:00 TCGX Closes $1.3 Billion Fund Amid Investor Surge
- 08.10.2025 16:00 AstraZeneca and Daiichi’s Datroway trumps chemo in first-line breast cancer
- 08.10.2025 15:00 Mid-stage health tech startups struggling to raise, report finds
- 08.10.2025 14:00 FDA Launches Pilot Program to Improve US Generic Drug Manufacturing
- 08.10.2025 12:59 CDC Approves Updated Covid-19 and Chickenpox Vaccine Recommendations
- 08.10.2025 12:02 Terumo Completes Acquisition of WuXi Biologics Drug Product Plant in Leverkusen, Germany
- 08.10.2025 11:00 Mary Brunkow, Fred Ramsdell, Shimon Sakaguchi win Nobel for Treg cell findings
- 08.10.2025 10:03 AstraZeneca, Daiichi drug extends survival in hard-to-treat breast cancer
- 08.10.2025 09:01 Biogen Ordered to Pay $124 Million in Patent Dispute with Genentech
- 08.10.2025 07:01 Supreme Court Addresses Medical Malpractice Issues
- 08.10.2025 05:01 Funds Dry Up for mRNA Vaccines Amid US Political Storm
- 08.10.2025 04:02 Skye shares crash as obesity drug falls short in key study
- 08.10.2025 03:00 How CDMS Support Services Can Make or Break Complex Study Rescues
- 08.10.2025 02:01 Gilead delays arrival of Biktarvy copycats; CDC updates vaccine schedule
- 08.10.2025 01:01 New Study Links Sugar Protein Modifications to Depression in Mice
- 07.10.2025 21:01 BD BodyComm™ Version 3.3 Software Faces Transition Challenges to Windows 11
- 07.10.2025 18:00 Dyadic Applied BioSolutions Achieves Milestone Payments and Progresses in Key Collaborations
- 07.10.2025 16:03 uniQure’s Gene Therapy for Huntington’s Disease Holds Blockbuster Potential
- 07.10.2025 15:02 Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy
- 07.10.2025 12:00 Cell therapy CDMO Mytos unveils its first facility in the UK
- 07.10.2025 11:02 Pfizer Acquires Metsera for $4.9 Billion, Falling Short of Board’s Expectations
- 07.10.2025 09:04 Amgen Unveils DTC Platform with 60% Discount on Repatha, Giving US Lowest Price of G7 Nations
- 07.10.2025 08:00 Chiesi Group Enters CRISPR Arena with Arbor Biotechnologies Partnership
- 07.10.2025 06:01 Bioindustry Faces Talent Crunch and Regulatory Strain
- 07.10.2025 05:00 Skye Bioscience’s Obesity Drug Candidate Fails Mid-Stage Study
- 07.10.2025 04:00 FDA Backs Generics Onshoring Push with ANDA Priority Scheme
- 07.10.2025 03:00 Eli Lilly Earmarks $1B-Plus for Contract Manufacturing Partnerships in India
- 07.10.2025 02:00 Trogenix Secures $95 Million Series A Funding Led by Eli Lilly for Innovative Brain Cancer Therapy
- 07.10.2025 01:00 AstraZeneca, Daiichi Sankyo report Phase 3 win for Datroway in triple negative breast cancer
- 07.10.2025 00:01 Myeloid Therapeutics rebrands as Create Medicines to reflect expanded pipeline
- 06.10.2025 23:00 AZ, Daiichi Achieve Landmark Results for ADC Datroway in Triple-Negative Breast Cancer
- 06.10.2025 22:00 McMaster University and MIT Discover New Antibiotic for IBD
- 06.10.2025 21:01 T Cell Engagers Could Redefine Autoimmune Treatment Landscape
- 06.10.2025 20:04 2025 Nobel Prize in Medicine awarded to Brunkow, Ramsdell, and Sakaguchi for breakthroughs in immune system research
- 06.10.2025 18:00 European Pharmaceutical Policy Overhaul Approaches Finalization, Impacting Drugmaker Investments
- 06.10.2025 17:02 Supreme Court Case on Conversion Therapy Could Reshape Medical Regulations
- 06.10.2025 15:04 Q3 Biopharma Layoffs Hold Steady, Setting 2025 Up to Break Last Year’s High
- 06.10.2025 14:02 Onshoring Initiatives May Undermine Biosimilar and Generic Supply Chains
- 06.10.2025 13:01 Telehealth’s Shift: From Patient Access to Drug Marketing Dominance
- 06.10.2025 11:00 MHRA Launches Patient Safety Essay Competition for 2025
- 06.10.2025 10:07 Health Canada Approves Santhera’s Agamree to Treat DMD
- 06.10.2025 07:01 Pfizer’s Agreement with Trump Spurs 14% Stock Surge
- 06.10.2025 06:00 Trogenix raises $95M Series A as brain cancer program nears clinic
- 06.10.2025 04:04 Pfizer Secures ‘Most Favored Nation’ Deal Amidst Industry Shifts
- 06.10.2025 02:02 Colorado Board Sets First Payment Limit on Amgen’s Enbrel, Paving the Way for National Trends
- 06.10.2025 01:00 FDA’s Listening Session on Cell and Gene Therapy: Key Insights for Industry Stakeholders
- 05.10.2025 23:06 Largest Genetic Map of Human Metabolism Created
- 05.10.2025 22:01 Unclogging the Downstream Bottlenecks in Bioprocessing
- 05.10.2025 21:00 Legal Pressure Builds Around FDA’s New DTC Pharma Ad Crackdown
- 05.10.2025 20:00 BridgeBio’s GondolaBio bet skirts industry’s focus on small pipelines
- 05.10.2025 19:00 FDA Warns Against Contra Reumas Due to Hidden Drug Ingredients
- 05.10.2025 18:00 Jazz and Roche’s Zepzelca-Tecentriq wins FDA ES-SCLC approval
- 05.10.2025 17:00 Biotech Pioneer William Rutter Remembered for His Impact on Industry
- 05.10.2025 16:00 Transcription Factors: From Undruggable to New Drug Opportunities
- 05.10.2025 15:01 AMR Drugs and Diagnostics Must Evolve in Tandem
- 05.10.2025 13:01 Rapid and Precise Quantitation of Surfactants in Protein Formulations
- 05.10.2025 12:00 EpiPlex Platform Enhances RNA Modification Analysis from Minimal Inputs
- 05.10.2025 11:00 Dissecting the CAR T-Cell Membrane Using the Proximity Network Assay
- 05.10.2025 10:00 FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing
- 05.10.2025 07:01 FDA Approves Zepzelca-Tecentriq Combination for Lung Cancer Treatment
- 05.10.2025 06:01 Rocket Withdraws FDA Application for Gene Therapy Targeting Fanconi Anemia
- 05.10.2025 05:00 Rocket ditches blood disorder gene therapy in ongoing pipeline pivot
- 05.10.2025 04:00 Bridging the Patient-Provider Gap with 360° Data
- 05.10.2025 03:00 AI could transform healthcare. Can safety-net providers keep up?
- 05.10.2025 02:00 FDA Approves Second Generic Version of Mifepristone
- 05.10.2025 01:00 Ovid Therapeutics Stock Surges Following Positive Phase 1 Data and $81M PIPE Financing
- 04.10.2025 23:00 EMA Management Board Highlights Key Achievements in October 2025 Meeting
- 04.10.2025 22:01 New Drugs Regulatory Program Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation
- 04.10.2025 20:05 MHRA Establishes Register of Licensed Manufacturing Sites for Human and Veterinary Medicines
- 04.10.2025 19:00 UK Brokers Authorized to Deal in Human Medicines Now Listed
- 04.10.2025 18:04 UK Companies Face Licence Terminations for Medicine Manufacturing and Wholesale
- 04.10.2025 17:03 UK Establishes Register of Licensed Wholesale Distribution Sites for Human Medicines
- 04.10.2025 16:00 FDA Approves New Generic Mifepristone Amidst Political Controversy
- 04.10.2025 15:00 The NIH’s $50 million autism bet
- 04.10.2025 13:01 Advocacy Groups Urge Antitrust Investigation into Big Pharma’s U.K. Withdrawal
- 04.10.2025 12:00 Cidara Secures Up to $339M BARDA Award for Flu Prevention Candidate
- 04.10.2025 10:00 Biopharma Faces Leadership Gap as Female CEOs Depart: Report Highlights Ongoing Challenges
- 04.10.2025 08:00 Amgen’s Phase III data supports FDA label expansion of Repatha
- 04.10.2025 07:00 FDA Approves Jazz and Roche’s Combination Therapy as First-Line Treatment for Small Cell Lung Cancer
- 04.10.2025 06:00 PRAC Meeting Highlights: Key Outcomes from 29 September – 2 October 2025
- 04.10.2025 05:00 Cidara Secures Up to $339 Million from BARDA for Non-Vaccine Flu Candidate Development
- 04.10.2025 04:00 Nicole Kleinstreuer Leads NIH Initiative to Reduce Animal Use in Biomedical Research
- 04.10.2025 03:04 Trump Administration Delays Proposal to Close Medicare Drug Price Negotiation Loophole
- 03.10.2025 23:02 GSK Overturns UK Watchdog’s Most Serious Sanction in COVID Press Release Row
- 03.10.2025 22:01 Top Universities Must Revamp Courses to Address Cell and Gene Therapy Skills Gap
- 03.10.2025 21:03 Half of Merck’s sales are in jeopardy. Can Keytruda’s sequel save the day?
- 03.10.2025 20:02 Kidney Organoids Reveal How APOL1 Mutations Trigger Disease
- 03.10.2025 18:00 Indivior Halts Marketing of Opvee Amid Controversy and Legal Settlement
- 03.10.2025 17:00 White House Confirms 100% Tariffs on Some Brand Drugs Following Section 232 Investigation
- 03.10.2025 16:00 Symbiosis Expands Sterile Manufacturing Capacity With Fill/Finish Line Qualification
- 03.10.2025 15:04 Trump’s MFN Deadline Passed Without Action
- 03.10.2025 13:00 FDA Official Questions Safety of Voclosporin, Sparking Controversy Among Biotech Investors
- 03.10.2025 12:00 Indivior to Discontinue Opvee Marketing After New York Settlement
- 03.10.2025 11:00 Sharp Appoints Samantha Wilson Jones as General Counsel
- 03.10.2025 10:01 Faeth Therapeutics Expands R&D Platform to Address Neurocognitive Impairment in Tyrosinemia Type 1
- 03.10.2025 08:01 Crystalys Secures $205M to Expand Gout Treatment from Japan to US and Europe
- 03.10.2025 06:00 Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer Pipeline
- 03.10.2025 05:00 Crystalys Debuts with $205M and Plans for a Better Gout Drug
- 03.10.2025 04:09 The CDC is switching back to ‘monkeypox’
- 03.10.2025 01:01 Korea’s Boryung Acquires Rights to Sanofi’s Taxotere for $205M, Expanding Oncology Portfolio
- 03.10.2025 00:00 Novartis earns FDA’s ire for ‘misleading’ romantic storyline of Fabhalta TV ad
- 02.10.2025 23:08 Opus Reports Vision Improvement in Teens with Gene Therapy for Rare Blindness
- 02.10.2025 21:00 J&J Secures FDA Approval for Tremfya in Pediatric Psoriasis
- 02.10.2025 20:03 Star Raises Another $125M for Its Blood Disease Drug
- 02.10.2025 19:07 Star Therapeutics Secures $125M Series D Funding as It Enters Phase 3 Trials for Bleeding Disorders
- 02.10.2025 18:02 NMPA Approves Eisai and Biogen for Leqembi IV Maintenance Dosing
- 02.10.2025 16:00 Oral Liquid Dosage Forms: Emerging Trends and Key Challenges
- 02.10.2025 15:03 Rovi Acquires BMS Facility in Phoenix as Part of $250M Manufacturing Deal
- 02.10.2025 14:00 AnaptysBio Plans to Split Biotech and Jemperli Royalties into Separate Businesses
- 02.10.2025 13:00 ERS 2025: APG808 to Address Need for Biologic for Moderate Asthma
- 02.10.2025 12:01 Eli Lilly Expands Biotech Support with New Gateway Labs in San Diego
- 02.10.2025 11:00 Universal Hepatitis B Birth-Dose Vaccination Faces Potential Repeal in the U.S.
- 02.10.2025 10:00 Urgent Surgical Intervention Needed to Save Life of Two-Month-Old in El Salvador
- 02.10.2025 09:00 Genmab to acquire Merus shares for $8bn
- 02.10.2025 08:01 AC Immune’s Tau-targeting therapy shows promise in early Alzheimer’s trial
- 02.10.2025 07:01 Biogen Supports Friedreich Ataxia Web Series Featuring Bill Nye
- 02.10.2025 05:00 CRISPR’s Origin Story: RNA Splitting Sparked Rise of Type V Systems
- 02.10.2025 03:07 FDA Regulator Raises Concerns Over Voclosporin, Sparking Investor Speculation
- 02.10.2025 02:00 Anti-Aging Enzyme Class Revealed by New TOR Inhibitor
- 02.10.2025 01:02 Quality and Regulatory Predictability: Shaping USP Standards – 12/11/2025
- 02.10.2025 00:00 CDER Launches Quantitative Medicine Center of Excellence to Enhance Drug Development
- 01.10.2025 23:00 CDER Director Signals FDA’s Reevaluation of Surrogate Endpoints in Drug Approval
- 01.10.2025 22:17 Antibiotic Pierces Bacterial Armor to Address Drug-Resistant Infections
- 01.10.2025 21:00 FDA Establishes Quantitative Medicine Center of Excellence to Enhance Drug Development
- 01.10.2025 20:01 mRNA Vaccine Suppresses Neovascularization in Mouse Models of Macular Degeneration
- 01.10.2025 19:02 Orexo US Awarded $8 Million by BARDA for OX390 Development Partnership
- 01.10.2025 18:00 Cadence Launches ROCS X, Revolutionizing Molecular Search with AI Technology
- 01.10.2025 17:03 Homeopathic Products Lack FDA Oversight, Raising Safety Concerns
- 01.10.2025 16:01 James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise
- 01.10.2025 14:01 Merck Unveils Data from 2nd Winrevair PAH Study Previously Halted for Efficacy
- 01.10.2025 13:00 Advanced Organoid Platforms Enhance Understanding of Cancer and Viral Infections
- 01.10.2025 12:01 Future-Proofing Your Cell and Gene Therapy
- 01.10.2025 11:00 Genmab Acquires Merus for $8 Billion, Highlighting Longstanding Interest
- 01.10.2025 10:00 67% of First Responder Organizations Implement New Cybersecurity Measures
- 01.10.2025 08:01 Doctors Challenge Cigna’s New Policy That Could Reduce Reimbursements
- 01.10.2025 07:01 White House deadline brings flurry of pharma price cutdowns
- 01.10.2025 05:00 FDA to Address Financial Transparency and Efficiency of User Fee Acts on September 30, 2025
- 01.10.2025 04:04 Emma Walmsley, big pharma’s first female CEO, to depart GSK
- 01.10.2025 03:06 Genmab to acquire closely watched cancer drug in $8B Merus buyout
- 01.10.2025 02:00 Larimar’s Friedreich’s Ataxia Drug Faces Setback Due to Allergic Reactions
- 01.10.2025 01:00 Enanta’s RSV Treatment Misses Primary Endpoint in Phase 2b Study, Yet Subgroup Data Offers Hope
- 30.09.2025 23:03 Advanced Pharmaceutical Manufacturing: APM Technologies Transforming Drug Production
- 30.09.2025 22:00 IO Biotech to Run Another Study for Cancer Vaccine; Boehringer Ends Mid-Stage IPF Trial
- 30.09.2025 21:01 Warning: Serious cardiovascular events don’t come out of the blue
- 30.09.2025 20:00 Moonlake shares crash on mixed study results for immune drug
- 30.09.2025 19:00 GSK Appoints Luke Miels as New CEO Amid Strategic Challenges
- 30.09.2025 18:03 University of Oregon Research Reveals Chlorate-Antibiotic Combination Enhances Chronic Wound Healing
- 30.09.2025 17:01 Wysa Expands Offerings with Acquisition of Kins, a Physical Therapy Startup
- 30.09.2025 16:02 MMR Vaccine Concerns Addressed at AAP National Conference
- 30.09.2025 15:00 Lisa Suennen Leads AHA Ventures, Bridging Science and Business Amid Funding Challenges
- 30.09.2025 14:01 New CDMO on the Bloc: Rezon Bio Debuts with Two Plants to Tackle Biologics Contract Work in Europe
- 30.09.2025 12:00 AZ, Daiichi’s Enhertu Flexes Early Breast Cancer Prowess with Another Trial Win, Topping Roche’s Kadcyla
- 30.09.2025 11:00 Kedrion Secures FDA Approval for Qivigy, Unveils US Investment Strategy
- 30.09.2025 09:00 Novartis, Boehringer DTC platforms slash prices for Cosentyx, Spiriva Respimat
- 30.09.2025 08:00 GSK Appoints Luke Miels as New CEO, Succeeding Emma Walmsley on January 1
- 30.09.2025 06:15 The Dangerous Second Life of Medical Waste
- 30.09.2025 04:01 AstraZeneca plots US stock listing amid industry pullback from Britain
- 30.09.2025 02:59 Facing Pricing Pressure, PhRMA Plans New Website to Highlight Industry’s Direct Purchasing Programs
- 30.09.2025 02:01 Regeneron’s Evkeeza Gains FDA Approval for Young HoFH Patients
- 30.09.2025 01:01 Genmab Acquires Merus for $8 Billion, Targeting Head and Neck Cancer Market
- 29.09.2025 23:05 Softgel and lipid-based formulations: An opportunity to optimize performance for challenging therapeutics
- 29.09.2025 22:01 MoonLake’s Sonelokimab Faces Disastrous Phase 3 Trial Results in Autoimmune Drug Development
- 29.09.2025 21:06 Dementia Cases Projected to Surge: A Call for Change in Dialogue and Strategy
- 29.09.2025 20:01 Cigna’s New Downcoding Policy Raises Concerns for Physicians
- 29.09.2025 17:03 EMA Publishes Draft Reflection Paper on Patient Experience Data for Public Consultation
- 29.09.2025 14:00 Amgen to invest $650m in US manufacturing network expansion
- 29.09.2025 13:00 Pharma leaders urged to invest early in data to improve launch success
- 29.09.2025 12:00 GSK CEO Walmsley to Step Down, Succeeded by Commercial Lead Luke Miels
- 29.09.2025 11:00 GSK’s Emma Walmsley to step down as CEO in shock move, giving way to commercial lead Miels
- 28.09.2025 23:00 uniQure Shares Surge to Five-Year High Following Breakthrough Huntington’s Data
- 28.09.2025 22:01 Mifepristone Marks 25 Years of Impact on Abortion Access Amidst Regulatory Challenges
- 28.09.2025 18:00 STAT Encourages Dialogue on Public Health Perspectives in Life Sciences
- 28.09.2025 17:03 Pfizer Expands Portfolio with GLP-1 Acquisition Amid Regulatory Challenges
- 28.09.2025 13:00 Congress Faces Deadline to Extend Hospital Care at Home Program
- 28.09.2025 12:00 Tuned Toxin Expression Helps Candida albicans Evade Detection in the Mouth
- 28.09.2025 11:07 Pan-Cancer Immunotherapy Avoids Healthy Tissue by Targeting Glycans
- 28.09.2025 10:00 Concept Life Sciences Expands Integrated Drug Discovery Facilities
- 28.09.2025 09:01 Appeals court rejects Novartis’ attempt to block Entresto generics
- 28.09.2025 07:01 Mission BioCapital Raises $134M for Sixth Biotech Investment Fund
- 28.09.2025 06:04 MedWatch: The FDA Safety Information and Adverse Event Reporting Program
- 28.09.2025 05:00 Navigating the Fill Finish Process – e-book
- 28.09.2025 04:00 Almost 30% of Industry-Funded Research Goes Unpublished, New Study Says
- 28.09.2025 03:01 FDA Confirms Kratom is Not Lawfully Marketed in the U.S.
- 28.09.2025 01:06 Key exemptions could limit impact of Trump’s pharmaceutical tariffs
- 28.09.2025 00:00 Credence MedSystems & SMC Ltd. Pharma Services Announce Collaboration to Advance Dual Chamber Fill-Finish Capabilities
- 27.09.2025 22:59 Insights from BPI 2025: Key Takeaways for Pharma Professionals
- 27.09.2025 22:07 Trump’s New Tariff Threat Throws Months of Deals and Negotiations into Uncertainty
- 27.09.2025 21:04 AstraZeneca launches DTC platform amid US pricing pressures
- 27.09.2025 20:04 MHRA and partners unite to reaffirm prescription weight-loss medicine advertising rules
- 27.09.2025 19:01 Cancer Metabolism and RNA Regulation Linked by Single Protein in Leukemia
- 27.09.2025 17:01 EU Approves Eli Lilly’s Kisunla After Re-evaluation
- 27.09.2025 16:00 Crinetics Drug to Challenge Pharma ‘Goliaths’; FDA, ARPA Move to Speed Gene Therapies
- 27.09.2025 14:00 FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
- 27.09.2025 13:00 Biopharma Industry Faces Uncertainty Amid Trump Administration’s H-1B Visa Overhaul
- 27.09.2025 12:02 Immuneering Reports 86% Nine-Month Survival Rate in First-Line Pancreatic Cancer Trial, Eyes Phase 3
- 27.09.2025 08:04 Arcturus Sues AbbVie Over Capstan-Related Trade Secrets Claim
- 27.09.2025 07:06 FDA Unveils Trio of New Draft Guidances to Help Cell and Gene Therapy Developers
- 27.09.2025 06:03 Anthony Letai of Dana-Farber is front-runner to lead National Cancer Institute
- 27.09.2025 05:00 UniQure to seek approval of Huntington’s gene therapy after trial win
- 27.09.2025 03:00 Eli Lilly and Novo Nordisk Prepare for Oral GLP-1RA Approval, Shaping the Obesity Market
- 27.09.2025 02:01 Hovione & Microinnova Partner to Advance Modular Flow Chemistry for Multi-Purpose Manufacturing
- 27.09.2025 01:04 Andrea Wagner on Building PharmaPhixx and Breaking Barriers
- 27.09.2025 00:02 Future-Ready Reliability: Practical Insights into Pharma 4.0
- 26.09.2025 23:01 Smarter DMPK Strategies for Preclinical Oligonucleotide Development: Accelerate Progress & Enhance Safety
- 26.09.2025 22:00 HPAPI Outsourcing Market Projected to Reach $8.05 Billion by 2024
- 26.09.2025 20:00 CDMO 2030: What the Next Generation of Sponsors Will Demand
- 26.09.2025 19:04 Pharma Packaging Customization: Better Late Than Never
- 26.09.2025 18:01 Completed PDUFA VII Deliverables Enhance Drug Approval Process
- 26.09.2025 17:02 Tying Advanced Biomanufacturing to a Clinic
- 26.09.2025 16:00 Acadia to Scrap Prader-Willi Drug After Study Setback
- 26.09.2025 14:04 Biogen’s High-Dose Spinraza Rejected by FDA Due to CMC Issues
- 26.09.2025 13:01 The ‘HIPAA-compliant’ Myth and Other Health Privacy Fallacies Exposed
- 26.09.2025 12:01 Acadia Grounds Prader-Willi Candidate After Trial Failure, Leaving the Market to Soleno
- 26.09.2025 11:04 AI-Designed Protein Switches Control Drugs with Speed
- 26.09.2025 10:00 FDA Delays Approval Decision for Sanofi’s MS Treatment Tolebrutinib
- 26.09.2025 09:02 Hengrui and Glenmark Forge $1.1 Billion ADC Licensing Agreement
- 26.09.2025 07:00 Harmony Biosciences’ Cannabidiol Drug Fails Phase 3 Trial in Fragile X
- 26.09.2025 06:04 BMJ Group Retracts Study on Apple Cider Vinegar for Weight Loss
- 26.09.2025 04:00 Uniqure’s Gene Therapy Shows 75% Efficacy in Huntington’s Disease Progression
- 26.09.2025 02:00 Pharma’s Next Generation of Antibodies Takes a ‘More is Better’ Approach
- 26.09.2025 01:03 Herb-based Bioprocessing Shows Promise Against Drug-resistant Infections
- 26.09.2025 00:00 RA and Forbion Back Sparrow’s $95M Series B for Type 2 Diabetes Drug
- 25.09.2025 23:08 Acadia Pharmaceuticals’ Experimental Drug Fails Late-Stage Study for Prader-Willi Syndrome
- 25.09.2025 20:02 Fujifilm Biotechnologies Cuts Ribbon on $3.2B Antibody Facility in NC
- 25.09.2025 19:01 Gates, Clinton Organizations Collaborate with Indian Manufacturers for $40 Generic PrEP Drug
- 25.09.2025 17:08 Marco Greco and Dr. Piotr Szymanski Elected as New Co-Chairs for EMA Working Parties
- 25.09.2025 16:03 Global Health Organizations Back Generic Production of Gilead’s HIV Prevention Drug
- 25.09.2025 14:02 Generics makers to sell Gilead’s Yeztugo at $40 a year under deals with Gates Foundation, others
- 25.09.2025 13:10 Eli Lilly to build $6.5bn orforglipron production site in Texas
- 25.09.2025 12:00 Medical Devices Granted Exceptional Use Authorisations by MHRA
- 25.09.2025 11:08 FDA Grants Priority Review for Daiichi Sankyo and AstraZeneca’s Enhertu sBLA
- 25.09.2025 10:01 Sanofi Ventures banks $625M to back young biotechs, digital health startups
- 25.09.2025 09:01 Glenmark Secures Rights to Hengrui’s ADC Competitor for $1.1 Billion
- 25.09.2025 08:00 Speculation Surrounds Trump’s Health Amid Political Turmoil
- 25.09.2025 07:01 TegMine and Boehringer Ingelheim Partner on Cancer Therapeutics
- 25.09.2025 06:04 Biogen plots resubmission after FDA turns down high-dose Spinraza in SMA, requests more production info
- 25.09.2025 05:00 Large Breast Cancer Screening Trial to Validate AI for Mammograms
- 25.09.2025 04:00 Six Organizations Compete to Establish Health AI Standards Amid Regulatory Gaps
- 25.09.2025 02:09 Federal Health Officials Warn Against Tylenol Use During Pregnancy Amidst Controversy
- 25.09.2025 00:10 Lilly to invest $6.5bn in API manufacturing facility in Texas
- 24.09.2025 21:05 CRISPR Study Unveils Distinct Oncogenic Behaviors of EML4-ALK Variants in Lung Tumors
- 24.09.2025 20:05 Lactate Infusion May Mimic Some Brain Health Benefits of Exercise
- 24.09.2025 19:00 Harvard Dean’s Testimony on Tylenol Declared Unreliable by Federal Judge
- 24.09.2025 16:01 FDA Approves Leucovorin for Autism Treatment, Opening Doors for Supplement Market
- 24.09.2025 14:00 FDA Warns Against Flexi Bion Due to Potentially Harmful Hidden Ingredients
- 24.09.2025 13:00 Pleio’s Madison Norman Highlights Human Connection in Health Tech
- 24.09.2025 12:07 Disparity in vaccine access between states roils patients, providers
- 24.09.2025 11:00 Catalent Opens New Global Corporate Headquarters in Tampa
- 24.09.2025 09:00 PacBio Expands into Carrier Screening with Enhanced PureTarget Products
- 24.09.2025 08:00 CDER Releases Updated Manual of Policies and Procedures (MAPP)
- 24.09.2025 07:01 MapLight Lines Up an IPO in Bid to Challenge Bristol Myers’ Schizophrenia Drug
- 24.09.2025 06:00 Pharma Giants Use UK as Leverage in European Market Dynamics
- 24.09.2025 05:01 FDA Rejects Lundbeck and Otsuka’s Rexulti for PTSD Following Negative Advisory Committee Vote
- 24.09.2025 04:00 Pfizer Reenters Obesity Drug Market with $4.9B Acquisition of Metsera
- 24.09.2025 03:00 MSD wins SC Keytruda approval, but analysts sceptical on impact
- 24.09.2025 01:04 Ionis Reports Success in Pivotal Trial for RNA Drug Targeting Alexander Disease, Plans FDA Submission
- 24.09.2025 00:04 FDA Delays Decision on Sanofi’s BTK Inhibitor; Roche Partners with Starpharma
- 23.09.2025 23:04 Bristol Myers to launch schizophrenia drug in the UK at the same price as in the US
- 23.09.2025 21:01 AI Tool for Prostate Cancer Gains Recognition Amidst Opaque Industry Payments
- 23.09.2025 19:00 Doctors Increasingly Reliant on Pharma Amid Eroding Trust
- 23.09.2025 16:00 Prime Medicine Stock Surges Over 144% Amid Positive Data and High-Profile Investments
- 23.09.2025 13:59 Avenzo Secures $60 Million for Investigational Cancer Treatments Licensed from China
- 23.09.2025 11:04 Health Officials Warn Against Tylenol Use During Pregnancy, Link to Autism Risk
- 23.09.2025 10:00 New Variations Guidelines to Streamline Lifecycle Management of Medicines
- 23.09.2025 08:10 Pfizer to Acquire Metsera for $4.9 Billion in Obesity Drug Push
- 23.09.2025 07:00 Bristol Myers Squibb to Set UK Pricing for Cobenfy at US Levels Amid Ongoing Pressure from Big Pharma
- 23.09.2025 05:00 MBX Biosciences’ Canvuparatide Achieves Primary Goal in Mid-Stage Trial for Chronic Hypoparathyroidism
- 23.09.2025 04:00 MBX Biosciences Reports Promising Phase 2 Results for Canvuparatide in Hypoparathyroidism
- 23.09.2025 03:00 Pfizer accelerates obesity drug development with $4.9B acquisition of Metsera
- 23.09.2025 01:02 FDA Approves Tremfya for Ulcerative Colitis, First IL-23 Inhibitor with Dual Dosing Options
- 23.09.2025 00:04 Stealth Bio’s Forzinity finally approved as first Barth syndrome therapy
- 22.09.2025 21:59 Most Doctors Believe Interactions with Pharma Erode Public Trust, Analysis Finds
- 22.09.2025 21:01 Gordon Guyatt Critiques Misuse of Gender-Affirming Care Reviews to Justify Bans
- 22.09.2025 20:01 Hospitals Face Financial Penalties for High Infection Rates, Leading to Testing Discouragement
- 22.09.2025 18:03 Ionis and Sobi’s Tryngolza gains approval in EU for FCS treatment
- 22.09.2025 17:03 Single Drug Could Stabilize Nearly All Mutated Versions of a Human GPCR
- 22.09.2025 16:02 Proactive CMC Strategies Essential for Successful Cell and Gene Therapies
- 22.09.2025 15:10 EmVenio Launches Innovative Platform to Enhance Clinical Trial Participation
- 22.09.2025 13:01 Astellas’ Izervay Gains Conditional Approval in Japan for GA Treatment
- 22.09.2025 12:01 Pharma Marketers Embrace AI’s Potential Amid Ongoing Concerns
- 22.09.2025 10:03 RFK Jr.’s Advisers Begin Revising Childhood Vaccine Schedule Amid Controversy
- 22.09.2025 09:04 Nobel Laureate Challenges ACIP Claims on Covid Vaccine Persistence
- 22.09.2025 07:00 Key federal vaccine panel tables vote on delaying newborn hepatitis B shot
- 22.09.2025 06:00 FDA Grants Accelerated Approval for Barth Syndrome Treatment Amid Regulatory Uncertainty
- 22.09.2025 05:01 CDC Panel Recasts COVID Vaccine Recommendations Amid Controversy
- 22.09.2025 04:06 Congress Fails to Pass Stopgap Funding, Leaving ACA Tax Credits in Uncertainty
- 22.09.2025 03:06 Federal vaccine panel remade by RFK Jr. votes to maintain insurance coverage for Covid shots
- 22.09.2025 02:02 Cellares Partners to Enhance Cell Q’s Commercial-Scale QC for Cell Therapy
- 22.09.2025 01:01 CDC Rescinds Telework Policy Amid Concerns for Employees with Disabilities
- 22.09.2025 00:00 Arvinas Reboots, Cuts More Staff; Porges Joins Lazard
- 21.09.2025 23:17 Pancreatic Cancer Progression Slowed by Antithrombin-Binding Heparan Sulfate in Mice
- 21.09.2025 22:01 Vicero Appoints Han Myint as Chief Medical Officer Amid Industry Shifts
- 21.09.2025 21:04 CDC Advisers Postpone Vote on Delaying Newborns’ Hepatitis B Vaccine
- 21.09.2025 20:00 FDA Issues 60 Warning Letters Targeting Compounded GLP-1 Drugs
- 21.09.2025 19:02 Process Intensification Drives Innovation in Analytical Technologies
- 21.09.2025 18:01 Federal Advisory Committee Restricts Access to MMRV Shot for Low-Income Children
- 21.09.2025 17:00 CDC Advocates for Gilead’s HIV Prevention Drug Amid CVS Coverage Controversy
- 21.09.2025 16:08 CRISPR Activation Restores SCN2A Loss, Improves Neurodevelopmental Outcomes in Mice
- 21.09.2025 15:04 CDC Panel Recommends Splitting Measles, Varicella Shots
- 21.09.2025 14:12 Oral Microbiome Linked to Future Risk of Pancreatic Cancer
- 21.09.2025 13:01 T.Rx Capital Secures Nearly $80 Million for Biotech Ventures, Co-Founded by Michael Langer
- 21.09.2025 12:04 Boston’s Bioprocessing Buzz: GEN Reports Live from BPI 2025
- 21.09.2025 11:00 Biogen Acquires Alcyone to Enhance RNA Drug Delivery
- 21.09.2025 10:00 Roche dives into MASH with $2.4B deal for 89bio
- 21.09.2025 09:07 Needle-Free Vaccine Delivery Enabled by Stretching the Skin
- 21.09.2025 08:02 UK Licensing Authority Authorizes New Orphan Medicinal Products
- 21.09.2025 05:01 Genetic Diversity of Malaria-Transmitting Mosquitoes Unveiled
- 21.09.2025 04:03 Fired CDC Director Claims RFK Jr. Seeks to Alter Childhood Vaccine Schedule
- 21.09.2025 03:03 Roivant’s Brepocitinib Shows Efficacy in Dermatomyositis Trial
- 21.09.2025 02:07 Organoids Recreate Native Kidney Architecture to Model Complex Disease in Mice
- 21.09.2025 01:08 Optimizing Chromatography for Therapeutic-Antibody Processing
- 20.09.2025 23:00 UK Revokes Licences of Multiple Medicine Manufacturers and Wholesalers
- 20.09.2025 22:00 Professor Richard FitzGerald appointed to the Commission on Human Medicines
- 20.09.2025 21:00 MHRA and Department for Education Embed Medicine Safety into School Curriculum to Empower Young People
- 20.09.2025 20:05 Big Pharma’s New Chapter: M&A, Metabolism & the Outsourcing Boom
- 20.09.2025 19:04 Pfizer Tops Annual Ranking as Pharma’s Revenue Landscape Shifts
- 20.09.2025 18:03 Bend Bioscience Expands Operations to Enhance Complex Drug Delivery Solutions
- 20.09.2025 17:00 CGT Outsourcing Market Set to Surge Amidst Challenges and Opportunities
- 20.09.2025 16:01 Optimizing Contamination Control in Cell & Gene Therapy
- 20.09.2025 15:00 Single-Use Technologies Transforming Biopharmaceutical Manufacturing
- 20.09.2025 13:00 Blood Plasma Processing: Every Drop Counts
- 20.09.2025 12:48 Early Choices, Lasting Impact in Cell & Gene Therapy
- 20.09.2025 12:42 CRO Services Market Projected to Reach $175.5 Billion by 2032
- 20.09.2025 10:35 Endpoints 11 Winners Announced Amid Industry Developments
- 17.09.2025 15:00 Abbott Promotes Heart Health Awareness Through Hallmark Movie Featuring HeartMates Community
- 17.09.2025 14:01 FDA Launches Pilot Grant Program for Standard Core Clinical Outcome Assessments
- 17.09.2025 13:00 Eli Lilly Must Pay $183.7 Million in Medicaid Rebate Case as Appeals Court Upholds Judgment
- 17.09.2025 12:03 Lilly’s UK Gateway Labs plans uncertain in new blow to region’s biopharma industry
- 17.09.2025 11:00 ‘Keep doing what you’re doing’: Marketing policy experts unfazed by threats to DTC drug advertising
- 17.09.2025 10:03 Middle East Biotech Fund Launches with $50 Million Investment Focus
- 17.09.2025 09:00 Trump Officials Investigate Link Between COVID Vaccines and Child Deaths Ahead of ACIP Meeting
- 17.09.2025 08:10 LB Pharmaceuticals Tops 2025 Biotech IPO List with $285M Nasdaq Debut
- 17.09.2025 08:09 Pfizer’s VEGF Bispecific Strategy Contrasts with Summit’s Disappointing Results
- 17.09.2025 08:00 FDA Enhances FAERS with Electronic Submission Capabilities
- 17.09.2025 07:37 Physicians Differentiate Between Scientific Publications and Promotional Materials in Drug Information
- 17.09.2025 07:29 Chronic Disease Treatment Ads Inspire Action in Two-Thirds of Patients: Survey
- 17.09.2025 07:02 Belite Bio Completes Phase 3 Trial of Tinlarebant for Stargardt Disease
- 17.09.2025 05:04 Wholesale Drug Distributors and Third-Party Logistics Providers Face Annual Licensure Reporting Requirements
- 17.09.2025 02:04 KalVista Reports Strong Sales in Early Launch of Hereditary Angioedema Drug
- 17.09.2025 01:05 Gilead Prevails in Whistleblower Lawsuit Over Alleged Hepatitis C Prescription Kickbacks
- 17.09.2025 00:04 Appeals court knocks back Novartis’ IRA challenge one week after rejecting bid by BMS, J&J
- 16.09.2025 22:01 AbbVie extends Rinvoq exclusivity by four years after generics settlements
- 16.09.2025 21:03 Kashiv Signs Deal with CRISTÁLIA for Xolair Biosimilar in LATAM
- 16.09.2025 20:01 GTCR to Acquire Generic Drug Maker Zentiva
- 16.09.2025 18:01 New QSAR Model Enhances Predictive Accuracy for Blood Brain Barrier Permeability
- 16.09.2025 17:04 AbbVie staves off Rinvoq generics until 2037
- 16.09.2025 15:09 Quantitative Medicine Center of Excellence (QM CoE) Launches Educational Resources
- 16.09.2025 14:01 Novartis Loses IRA Appeals Case Amidst Ongoing Industry Scrutiny
- 16.09.2025 13:07 Nonprescription Drugs Advisory Committee Enhances FDA Oversight
- 16.09.2025 12:00 XO Health Secures $52.2 Million in Funding to Expand Alternative Health Solutions
- 16.09.2025 11:05 Vinay Prasad Regains Chief Medical and Scientific Officer Roles at FDA
- 16.09.2025 10:03 Doctor Mike Calls on Healthcare, Pharma Leaders to Lean into Social Media to Rebuild Trust with Patients
- 16.09.2025 09:04 MSD Halts £1bn UK Expansion Amid Government-Big Pharma Tensions
- 16.09.2025 08:03 CDER Researchers Leverage Deep Learning to Enhance Patient Experience Insights
- 16.09.2025 07:01 Division of Applied Regulatory Science Showcases Innovative Projects
- 16.09.2025 04:00 LGC Opens $72 Million Chemical Plant in Ontario, Canada
- 16.09.2025 03:00 Intercept Withdraws Ocaliva from Market as FDA Halts Clinical Trials
- 16.09.2025 02:02 Hemophilia Gene Therapies Encounter Significant Adoption Barriers
- 16.09.2025 01:05 Trump Administration Considers Executive Order to Limit Drug Licensing Deals with China Biotechs
- 16.09.2025 00:07 The UK Faces Contagion Risk as Pharmaceutical R&D Investments Shift Abroad
- 15.09.2025 22:01 Novo Nordisk Mandates Office Return Amid 9,000 Job Cuts
- 15.09.2025 21:00 CDER Statistical Studies Innovate Measures of Adhesion to Assess Generic Products
- 15.09.2025 20:00 Lasker Award Recognizes Breakthroughs in Cystic Fibrosis Treatment
- 15.09.2025 19:00 CPHI Frankfurt 2025 to Welcome More Than 60,000 Pharma Professionals as the Global Event Returns to Germany
- 15.09.2025 17:00 AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med’s US stronghold until 2037
- 15.09.2025 16:00 Capvaxive Shows Strong Immune Response in Children at Risk of Pneumococcal Disease
- 15.09.2025 15:01 FDA Announces Annual Generic Drug Research Priorities Under GDUFA
- 15.09.2025 12:00 SEC Charges Former FibroGen CMO with Clinical Trial Data Manipulation
- 15.09.2025 10:03 Revolution Medicines Advances Lead RAS Blocker to Phase 3 for Frontline Pancreatic Cancer
- 15.09.2025 08:00 Merck’s Capvaxive Pneumococcal Vaccine Shows Promise in Pediatric Trials
- 15.09.2025 07:05 UK pharma industry risks losing world-leading status as investment plummets
- 15.09.2025 06:01 Chicago Private Equity Firm GTCR Acquires Zentiva for €4.1 Billion
- 15.09.2025 03:59 FibroGen pays SEC $1.2M over allegations former exec ‘reverse engineered’ roxadustat data
- 15.09.2025 01:03 Patient dies in Capsida study for rare brain disorder
- 15.09.2025 00:06 Sanofi’s Tzield gains approval in China for T1D management
- 14.09.2025 22:03 FDA Updates Biosimilar Product Information to Enhance Market Access
- 14.09.2025 21:08 Pharma’s Drug Discount Fight Intensifies as State 340B Cases Reach Higher Courts
- 14.09.2025 19:03 Biocon eyes generic semaglutide market for 2026
- 14.09.2025 17:01 FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- 14.09.2025 15:00 Genetic Metabolic Diseases Advisory Committee Roster Updated with Current Membership and Vacancies
- 14.09.2025 14:01 Hikal Faces FDA Warning Letter Over Contamination Complaints
- 14.09.2025 12:11 Top 20 Biopharma Market Caps Fall 5.7% Amid Industry Challenges
- 14.09.2025 11:01 Spectrum Laboratory Products, Inc. Issues Voluntary Worldwide Recall of Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient (API) Due to Discoloration of Product
- 14.09.2025 10:11 Avidity Biosciences Reports Positive Functional Outcomes for Duchenne Exon Skipping Drug Ahead of Regulatory Submission
- 14.09.2025 09:03 Trethera Completes Enrollment in Phase 1 Trial for TRE-515 in Advanced Solid Tumors
- 14.09.2025 08:00 Trump Tasks FDA to Crack Down on Misleading Drug Advertising
- 14.09.2025 07:00 PMV to Pursue FDA Approval in Ovarian Cancer; Amylyx Reveals $175M Offering
- 14.09.2025 05:04 FDA Blocks US Imports from Sun Pharma’s Halol Site Over Repeated Issues
- 14.09.2025 04:06 For the first PD-1xVEGF’s sake, Summit must submit to Big Pharma, stat
- 14.09.2025 02:05 Pharmas Must Embrace Relatability to Effectively Reach Patients
- 13.09.2025 20:03 Symeres Acquires DGr Pharma to Enhance Regulatory Expertise & Broadens Biopharma Capabilities
- 13.09.2025 19:03 ‘Landmines everywhere’: How pharma communications keep up under a political spotlight
- 13.09.2025 17:59 Karyopharm Completes Enrollment in Phase 3 SENTRY Trial for Myelofibrosis
- 13.09.2025 15:04 Trump Directs FDA to Limit DTC Drug Advertising, Legal Challenges Loom Ahead
- 13.09.2025 14:05 J&J’s ‘pretzel’ drug-device therapy wins US approval for certain bladder cancers
- 13.09.2025 13:00 Capricor Challenges FDA’s Rejection of Deramiocel for DMD
- 13.09.2025 11:04 J&J’s ‘practice-changing’ bladder cancer drug-device combo Inlexzo lands FDA nod
- 13.09.2025 10:00 Kytopen and BlueWhale Bio partner for cell therapy innovation
- 13.09.2025 09:01 Trump Administration Considers Severe Restrictions on US Pharmas Licensing Chinese Medications
- 13.09.2025 08:00 Novo Nordisk to Lay Off 9,000 Workers as New CEO Aims to Save $1.3B Annually by Late 2026
- 13.09.2025 07:03 Health Canada Approves Medison and Ipsen’s Bylvay to Treat ALGS
- 13.09.2025 06:04 CVS Files Antitrust Lawsuit Against Takeda Over Dexilant in Ongoing ‘Pay-for-Delay’ Controversy
- 13.09.2025 04:01 FDA’s Selective Approval Notifications Impact Oncology and Hematology Landscape
- 13.09.2025 02:03 FDA Launches Crackdown on Deceptive Drug Advertising
- 13.09.2025 01:00 FDA Updates Nonprescription Drugs Advisory Committee Roster
- 13.09.2025 00:05 FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer
- 12.09.2025 23:01 FDA Updates STIC Webpages for Antibacterial and Antifungal Drugs
- 12.09.2025 21:02 OPDP Advances Research on Prescription Drug Promotion
- 12.09.2025 20:01 OPDP Research Undergoes Peer Review Process
- 12.09.2025 18:02 Lundbeck to transfer commercial drugs to three partners in 27 markets
- 12.09.2025 16:01 Gilead Launches Innovative Campaign for Primary Biliary Cholangitis in Collaboration with ‘Project Runway’ Designer
- 12.09.2025 15:05 ICH M13B Webinar: Navigating the Draft ICH M13B Additional Strengths Biowaiver Guideline – 09/11/2025
- 12.09.2025 14:02 Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer
- 12.09.2025 12:05 Regeneron and Sandoz Patent Deal Clears Path for Eylea Biosimilar in 2026
- 12.09.2025 10:02 Trump Considers Exempting Pharmaceutical Products from Future Tariffs
- 12.09.2025 09:03 Alkermes’ success in Phase 2 narcolepsy trial is clouded by side effects
- 12.09.2025 08:00 Novartis snaps up promising ASCVD asset with Tourmaline acquisition
- 12.09.2025 07:01 Ideaya Biosciences Aims for Leadership in Precision Oncology with Promising Cancer Drug Trials
- 12.09.2025 06:00 US Government Signs $56M Smallpox/Mpox Vaccine Order Despite Political Disarray
- 12.09.2025 05:00 Regeneron’s allergy drugs clear Phase 3 trials, Ascletis targets quarterly GLP-1 shot
- 12.09.2025 04:04 ‘We want to feel heard’: Jamie-Lynn Sigler on how pharmas can better serve patients
- 12.09.2025 03:00 Injection Devices Market Set to Exceed $1 Trillion by 2030 Amid Shift to Subcutaneous Delivery
- 12.09.2025 02:02 Prescription Drug User Fee Amendments Enhance FDA Drug Approval Process
- 11.09.2025 22:00 Enlivex Secures Israeli Patent for Allocetra in Osteoarthritis Treatment
- 11.09.2025 21:01 Lilly Launches TuneLab Platform to Give Biotechnology Companies Access to AI-Enabled Drug Discovery Models Built Through Over $1 Billion in Research Investment
- 11.09.2025 20:00 Tagworks Pharmaceuticals Initiates Third Dose Level in Phase 1 Trial for TGW101
- 11.09.2025 19:00 Eli Lilly Launches TuneLab, Providing AI Models to Biotechs
- 11.09.2025 18:02 Novo’s Ozempic Price Cut Expected to Slow Market Share Erosion
- 11.09.2025 17:02 Lilly to seek Jaypirca label expansion for first-line CLL/SLL usage
- 11.09.2025 15:05 Ridge Bio Secures $25 Million to Enhance Antibody-Drug Conjugate Development
- 11.09.2025 14:06 Servier to acquire potential Fragile X syndrome treatment from Kaerus
- 11.09.2025 12:04 Sandoz Secures Settlement to Launch Biosimilar of Regeneron’s Eylea by 2026
- 11.09.2025 11:02 Permira Looks to Launch $4B Sale of CDMO Cambrex: FT
- 11.09.2025 10:03 Novo, Lilly Obesity Meds ‘Highly Cost-Effective’ but Sure to Strain Payer Budgets: ICER Report
- 11.09.2025 07:02 Samsung Biologics Secures $1.3 Billion Contract Manufacturing Deal Amid Tariff Uncertainty
- 11.09.2025 06:03 FDA Releases Final Guidance on E6(R3) Good Clinical Practice
- 11.09.2025 05:08 Endo Launches National Hand Health Month to Promote Xiaflex for Dupuytren’s Contracture
- 11.09.2025 04:01 Subcutaneous Injections: Innovations Addressing High-Viscosity Challenges
- 11.09.2025 03:00 Summit plays defense for the first time as questions loom over Phase 3 data
- 11.09.2025 02:02 New FDA Approval Pathway for N-of-1 Therapies Expected Soon, According to Prasad
- 11.09.2025 01:03 Hot Melt Extrusion: A Key Technology for Enhancing Solubility in Poorly Soluble Drugs
- 11.09.2025 00:25 Pfizer Reports New Covid-19 Vaccine Data from Open-Label Study
- 10.09.2025 21:02 Eli Lilly’s Jaypirca Shows ‘Striking’ Results in First-Line Lymphoma Patients
- 10.09.2025 20:02 Lonza and Ethris Collaborate to Develop Room-Temperature Stable mRNA Vaccines for Enhanced Mucosal Delivery
- 10.09.2025 19:01 WHO Adds GLP-1 Receptor Agonists to Essential Medicines List
- 10.09.2025 18:00 Dianthus’ selective complement inhibitor yields Phase 2 success in myasthenia gravis
- 10.09.2025 17:02 FDA to Host Sixth Online Controlled Substances Summit on September 11, 2025
- 10.09.2025 14:00 Daymark Health Secures $20 Million in Series A Funding for Cancer Care Innovation
- 10.09.2025 13:00 BridgeBio Reports Positive Phase 2 Results for Hypoparathyroidism Treatment
- 10.09.2025 12:00 Innovative Drug Delivery Approaches for GLP-1 Agonists Enhance Medication Adherence and Treatment Outcomes
- 10.09.2025 11:01 FDA Releases Newly Added Guidance Documents for Industry Stakeholders
- 10.09.2025 09:00 ALZpath’s pTau217 Antibody Set to Revolutionize Alzheimer’s Disease Diagnostics
- 10.09.2025 08:00 Lexicon Pharmaceuticals Submits Additional Data to FDA for Zynquista in Type 1 Diabetes
- 10.09.2025 07:01 Novonesis and Novo Nordisk Collaborate on Gut Microbiome Solutions for Metabolic Health
- 10.09.2025 05:59 Trump Carves Out Generics from 15% Tariffs in US-Japan Trade Deal
- 10.09.2025 05:01 Eli Lilly’s Jaypirca Achieves Primary Endpoint in Phase 3 Trial, Moving Toward First-Line CLL Use
- 10.09.2025 03:01 Rapport reports promising open-label study data for epilepsy pill, heads to Phase 3
- 10.09.2025 02:00 MD Anderson and Phoenix to Advance Cell and Gene Therapy Tech
- 10.09.2025 01:18 AstraZeneca’s Tagrisso and Chemotherapy Combination Reduces Mortality Risk by 23% in Advanced EGFR-Mutant Lung Cancer
- 10.09.2025 00:01 Hengrui Pharma Signs Exclusive License Agreement with Braveheart Bio for HRS-1893
- 09.09.2025 23:00 Mitochondrial Startup Secures £50M to Advance Lead Drug for ALS and Parkinson’s Disease
- 09.09.2025 22:00 Takeda’s Phase 3 Narcolepsy Trials Position It as Potential First Mover in Multibillion-Dollar Market
- 09.09.2025 21:09 Servier Acquires Medicxi Startup’s Fragile X Candidate for Up to $450M
- 09.09.2025 18:01 Summit's Global PD-1xVEGF Data Challenge Regional Consistency Claims but Show New Promising Survival Trend
- 09.09.2025 17:02 WCLC25: Summit Reports Full Phase 3 Data from First Group of Western Lung Cancer Patients
- 09.09.2025 16:01 Maraganore and Meanwell Collaborate as FDA Issues CRLs
- 09.09.2025 15:00 Navigating the Lipid Landscape: Overcoming Challenges in Lipid Sourcing for LNPs
- 09.09.2025 14:00 Rapafusyn Pharmaceuticals Secures $44M in Series A Funding
- 09.09.2025 12:05 Japan-made Generic Drugs Exempt from Trump’s Reciprocal Tariff
- 09.09.2025 11:00 TARGET DISCOVERY PLATFORM – Multi-Omics, SITESEEKER® Technology & the Future of Targeted Protein Degradation
- 09.09.2025 10:03 Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM
- 09.09.2025 08:00 Thermo Fisher Scientific Launches UltraComp eBeads to Enhance Flow Cytometry Precision
- 09.09.2025 07:01 Orexo’s AmorphOX Technology May Pave the Way for Intranasal GLP-1 Medication
- 09.09.2025 06:00 Point-of-care pharma marketing spending passes $1B milestone
- 09.09.2025 05:07 Perrigo Moves to Replace Striking Workers at NYC Plant Amid Strategy Shift
- 09.09.2025 04:00 Multiply Labs’ Biomanufacturing Robot to Slash Cell Therapy Costs
- 09.09.2025 03:06 BioNTech and DualityBio’s ADC Achieves Success in Late-Stage Breast Cancer Trial in China
- 09.09.2025 02:30 Astellas Launches Global Initiative to Combat Menopause Stigma in the Workplace
- 09.09.2025 01:00 Europe Issues Alert on Surge of Counterfeit Novo and Lilly Weight Loss Drugs
- 09.09.2025 00:02 GSK Expands mRNA Patent Litigation to Include Moderna’s Next-Generation COVID Shot
- 08.09.2025 23:04 RFK Jr. Defends Vaccine Policies in Heated Senate Hearing
- 08.09.2025 22:03 PRAC Initiates Review of Levamisole for Leukoencephalopathy Risk
- 08.09.2025 21:01 MRM Health Secures $64M to Advance Microbiome-Based Biotherapeutics
- 08.09.2025 20:03 EMA Warns of Rise in Illegal Weight Loss Drugs Marketed Online
- 08.09.2025 18:59 A rare kind of leadership, 30 years in the making
- 08.09.2025 18:42 Hengrui Pharmaceuticals Enters US Market with Cytokinetics Collaboration in Cardiology
- 08.09.2025 18:05 Gilead Sciences advances HIV prevention with new US partnership
- 08.09.2025 18:00 FDA Publishes Drug Rejection Letters for Ongoing Applications for the First Time
- 08.09.2025 17:54 RFK Jr. faces bipartisan backlash over vaccine policy decisions
- 08.09.2025 17:34 J&J, Bristol Myers Lose Appeals Cases Challenging Medicare Price Negotiation
- 08.09.2025 17:00 Bavarian Nordic’s Vimkunya Makes UK Debut Amid Ixchiq Suspension
- 08.09.2025 16:53 AstraZeneca Ends Manufacturing License at Indian Plant as It Exits the Site
- 08.09.2025 16:33 AbbVie’s Skyrizi and Rinvoq Maintain Dominance in August TV Drug Ad Spending
- 08.09.2025 16:01 MindMed Reveals Promising Phase 2b LSD Data for Generalized Anxiety Disorder
- 08.09.2025 15:14 RFK Jr. Blasts Pharma Industry, Touts mRNA Misinformation in Heated Senate Hearing
- 07.09.2025 08:09 Wave Life Sciences Reports RNA Therapy Results
- 07.09.2025 08:08 UK Pharma Trade Group Calls for Government Evaluation Overhaul
- 07.09.2025 08:06 Evaluating Promising Biotech Startups
- 07.09.2025 08:01 Ori Biotech Secures FDA Advanced Manufacturing Designation for IRO Platform
- 06.09.2025 09:50 Endpoints 11 Winners in 2025 Biotech Downturn
- 06.09.2025 09:48 Paul Offit Exits Key FDA Vaccine Panel
- 06.09.2025 09:45 FDA Enhances Generic Drug Competition
- 06.09.2025 07:13 Treeline Biosciences Secures $200M Funding Boost
- 06.09.2025 07:10 Artelo Biosciences Reports Promising Phase 2 CAReS Results
- 06.09.2025 07:08 PhRMA Launches Campaign on 340B Mark-Ups
- 06.09.2025 07:07 Mytos Expands Cell Therapy Manufacturing Partnerships
- 06.09.2025 07:05 Tyvaso Achieves Phase 3 Success in IPF Trial
- 05.09.2025 18:43 FDA’s Drug Safety Oversight Board Established
- 05.09.2025 18:40 Prasad Proposes New Vaccine Approval Strategies
- 05.09.2025 18:05 John Maraganore and Clive Meanwell Collaborate with $50M Investment to Combat Cardiovascular Disease
- 05.09.2025 18:03 Ionis Reports Positive Phase 3 Results for Tryngolza
- 04.09.2025 02:49 OMass Therapeutics Enters Exclusive Collaboration & License Agreement With Genentech
- 04.09.2025 02:46 Step Pharma Initiates Phase 1b Trial of Dencatistat for Essential Thrombocythaemia
- 03.09.2025 08:56 Novo’s Wegovy Outperforms Lilly’s Zepbound in Cardiovascular Risk Reduction
- 03.09.2025 08:33 CapVest Partners Acquires Stada, Abandoning IPO Strategy
- 02.09.2025 19:45 Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
- 02.09.2025 19:43 Eisai Secures FDA Approval for Leqembi Autoinjector, Enabling At-Home Maintenance Dosing
- 02.09.2025 15:13 Neon Health Secures $6 Million to Enhance Access to Specialty Drugs
- 02.09.2025 15:05 Zenas BioPharma & Royalty Pharma Enter Obexelimab Funding Agreement for up to $300 Million
- 02.09.2025 14:38 FDA Grants RMAT Designation to ETX101 for Dravet Syndrome
- 31.08.2025 19:21 Leadership Changes at Novo Nordisk and Rocket Pharma
- 31.08.2025 08:43 Physician Enthusiasm for Novo’s Wegovy Suggests Swift Uptake in Rezdiffra-Dominated MASH Market
- 31.08.2025 08:34 AbbVie’s Gilgamesh Acquisition: A Strategic Shift to Single-Asset Focus
- 31.08.2025 08:21 Zydus Therapeutics Secures Phase 2b/3 Victory in Liver Disease: A Strategic Move Against Gilead and Ipsen
- 31.08.2025 08:21 BeOne Advances Sonrotoclax: A Potential Breakthrough in Rare B Cell Lymphoma Treatment
- 31.08.2025 07:45 Outlook’s Wet AMD Candidate Faces Second FDA Rejection
- 31.08.2025 07:26 A New Dawn for GCA Treatment
- 30.08.2025 12:42 Turning Cancer on Its Head
- 30.08.2025 12:40 FDA’s Bold Move: Pfizer’s EUA Revoked
- 30.08.2025 12:39 Digital Twins: The Future of Obesity Treatment?
- 30.08.2025 11:15 Navigating Online Pharmacy Risks
- 30.08.2025 11:12 Disaster-Ready: Are We Prepared?